|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Pediatric Research Institute Mucociliary Physiology Laboratories, St. Louis University School of Medicine, St. Louis
2 From the Division of Pulmonary and Occupational Medicine, St. Louis University School of Medicine, St. Louis
Study objective: It has been reported that therapy with iodinated glycerol (IG) can improve the quality of life for patients with chronic bronchitis. The purpose of this study was to determine the effects of IG therapy on the quality of life, pulmonary function, and on the properties of sputum collected from adults with stable chronic bronchitis.
Design: Thirty-two week, double-blind, randomized, placebo-controlled cross-over study.
Setting: A university outpatient pulmonary clinic.
Participants: Twenty-six adults with stable chronic bronchitis completed the study; 28 completed the first treatment arm.
Interventions: Sixteen weeks each of placebo or IG 60 mg qid.
Measurements: First, pulmonary function by spirometry and plethysmography. Second, symptom score measured using a questionnaire. Third, sputum bulk and surface rheology, spinnability, mucociliary transportability and cough transportability.
Results: There were no significant changes in pulmonary function, clinical scores, or sputum properties related to therapy with IG. There was a significant improvement in the Global Petty score after both IG (p=0.01) and placebo (p<0.01) when compared with baseline, but there was no difference between treatment periods. There was a positive correlation between changes in the Global score during therapy and changes in sputum spinnability (p<0.01, r=0.38).
Conclusions: This study clearly demonstrates that in chronic bronchitis, 16 weeks of therapy with IG does not produce any appreciable effect on pulmonary function, well being, or on sputum viscoelasticity or clearability.
Key Words: chronic bronchitis cough iodinated glycerol mucociliary clearance mucolytics
Submitted on July 13, 1995
Accepted on September 27, 2007
This article has been cited by other articles:
![]() |
J. F. Donohue and J. A. Ohar Effects of Corticosteroids on Lung Function in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 152 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Mahler, P. Wire, D. Horstman, C.-N. Chang, J. Yates, T. Fischer, and T. Shah Effectiveness of Fluticasone Propionate and Salmeterol Combination Delivered via the Diskus Device in the Treatment of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1084 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J Poole and P. N Black BMJ, May 26, 2001; 322(7297): 1271 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Rubin An In Vitro Comparison of the Mucoactive Properties of Guaifenesin, Iodinated Glycerol, Surfactant, and Albuterol Chest, July 1, 1999; 116(1): 195 - 200. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |